Clinical trials recruiting in Thun, Switzerland

Phase breakdown

Conditions recruiting in Thun, Switzerland

Recruiting trials in Thun, Switzerland

• A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
  NCT06312176 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
  NCT07361510 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)
  NCT07149649 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%
  NCT07020065 · Phase: Phase 2 · Ages: 70 Years and older · Sex: All (male and female)
• Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
  NCT06393374 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Stress Reduction Through Acupuncture
  NCT07132034 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female
• The SwissPrEPared Study
  NCT03893188 · Phase: Not specified · Ages: 16 Years to 120 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Thun, Switzerland?

7 recruiting trials have at least one study site in Thun, Switzerland.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.